Today: 21 June 2026

Amicus Therapeutics (FOLD) Stock Jumps on BioMarin’s $4.8B Buyout: Latest News, Forecasts, and Deal Analysis as of Dec. 20, 2025

Amicus Therapeutics (FOLD) Stock Jumps on BioMarin’s $4.8B Buyout: Latest News, Forecasts, and Deal Analysis as of Dec. 20, 2025

BioMarin Pharmaceutical will acquire Amicus Therapeutics in an all-cash deal valued at $4.8 billion, offering $14.50 per share. Amicus stock surged about 30% after the Dec. 19 announcement, trading near $14.18 as of Dec. 20. The deal awaits regulatory and shareholder approval, with closing expected in Q2 2026. Trading volume spiked as investors focused on merger risk and timing.
21 December 2025
··
Warner Bros. Discovery Stock (WBD) Forecast: Netflix Merger vs. Paramount’s $30 Bid Puts Shares in Deal-Driven Limbo (Dec. 20, 2025)

Warner Bros. Discovery Stock (WBD) Forecast: Netflix Merger vs. Paramount’s $30 Bid Puts Shares in Deal-Driven Limbo (Dec. 20, 2025)

Warner Bros. Discovery’s board urged shareholders to reject Paramount Skydance’s $30-per-share all-cash tender offer, citing financing concerns and a potential $4.3 billion cost if the Netflix deal is abandoned. WBD stock closed at $27.77 on Dec. 19, near Netflix’s $27.75 per-share offer. Netflix reaffirmed its commitment to its $72 billion deal. Paramount continues to push its cash bid.
21 December 2025
···
BigBear.ai Stock (BBAI) News, Forecasts and Analyst Views on Dec. 20, 2025: Border-Security Partnership Fuels Momentum as Ask Sage Deal Looms

BigBear.ai Stock (BBAI) News, Forecasts and Analyst Views on Dec. 20, 2025: Border-Security Partnership Fuels Momentum as Ask Sage Deal Looms

BigBear.ai shares surged to $6.26 on Dec. 19, with trading volume topping 218 million after announcing a partnership with radar firm C Speed to deploy its ConductorOS AI platform for real-time threat detection. The company is also in focus over a $250 million Ask Sage acquisition deal and an upcoming share-authorization vote.
21 December 2025
···
Altria (MO) Stock in Focus: FDA Clears on! PLUS Nicotine Pouches, Dividend Dates, and the Latest Analyst Forecasts Into 2026

Altria (MO) Stock in Focus: FDA Clears on! PLUS Nicotine Pouches, Dividend Dates, and the Latest Analyst Forecasts Into 2026

The FDA late Friday authorized marketing of six on! PLUS nicotine pouch products, the first such decision under a new pilot review program. Altria shares closed at $58.07, market cap $97.48 billion, ahead of a key dividend ex-date and after the company confirmed plans to resume retail and online sales for the approved pouches. The authorization covers three flavors in two strengths, with strict packaging and marketing restrictions.
21 December 2025
··
NVIDIA Stock (NVDA) News, Forecasts and Analyst Outlook After Dec. 20, 2025: China Export Review, Blackwell “Cloud Loophole,” and 2026 Catalysts

NVIDIA Stock (NVDA) News, Forecasts and Analyst Outlook After Dec. 20, 2025: China Export Review, Blackwell “Cloud Loophole,” and 2026 Catalysts

Nvidia shares closed near $181 on Dec. 19, 2025, with market cap estimates around $4.4 trillion. Reports surfaced that China’s Tencent may be accessing banned Nvidia Blackwell AI chips via overseas cloud providers. U.S. officials also launched an interagency review that could allow H200 chip sales to China. Wall Street analysts described Nvidia as “cheap” by historical standards.
21 December 2025
·
Uber Stock (NYSE: UBER) News, Forecasts and Analysis on Dec. 20, 2025: Robotaxi Fears, FTC Lawsuit Headlines, and Wall Street’s Next Targets

Uber Stock (NYSE: UBER) News, Forecasts and Analysis on Dec. 20, 2025: Robotaxi Fears, FTC Lawsuit Headlines, and Wall Street’s Next Targets

Uber closed at $79.31 on Dec. 19, 2025, down about 20% from its fall peak but up for the year. The company faces renewed regulatory pressure after the FTC and 21 states filed an amended lawsuit over Uber One practices, sending shares down over 3%. Investors remain focused on legal risks and competition from robotaxis as Uber continues to post profits and expand its platform.
21 December 2025
·
Caterpillar (CAT) Stock News & Forecasts: Analyst Price Targets, Dividend Update, and 2026 Outlook as of Dec. 20, 2025

Caterpillar (CAT) Stock News & Forecasts: Analyst Price Targets, Dividend Update, and 2026 Outlook as of Dec. 20, 2025

Caterpillar shares closed at $576.22 on Dec. 19, up 1.84% after a volatile week that saw the stock drop from a Dec. 12 close of $597.89. Financial Enhancement Group sharply increased its CAT holdings in Q3, while Jackson Square Capital reduced its position, according to new filings. Insiders sold 79,061 shares worth about $41.95 million last quarter.
21 December 2025
·
CrowdStrike Stock (CRWD) News, Forecasts and Analyst Outlook: What’s Driving Shares as of Dec. 20, 2025

CrowdStrike Stock (CRWD) News, Forecasts and Analyst Outlook: What’s Driving Shares as of Dec. 20, 2025

CrowdStrike shares closed at $481.28 on Dec. 19, 2025, after trading as high as $489.20, with volume near 4.64 million shares. The stock’s movement follows strong Q3 FY2026 results: revenue rose 22% to $1.234 billion, and the company raised full-year guidance. Wall Street focus remains on annual recurring revenue and the pace of new customer growth amid ongoing AI-driven product expansion.
21 December 2025
·
AbbVie Stock (ABBV) Outlook: Drug‑Pricing Deal Headlines, Fresh Analyst Targets, and the 2026 Catalysts Investors Are Watching

AbbVie Stock (ABBV) Outlook: Drug‑Pricing Deal Headlines, Fresh Analyst Targets, and the 2026 Catalysts Investors Are Watching

AbbVie shares closed at $226.82 on Friday, up 1.8%, nearing a 52-week high with a market cap near $400 billion. U.S. drug pricing policy returned to focus after the Trump administration announced agreements with nine drugmakers, excluding AbbVie, which remains in upcoming negotiations. New Medicare pilot programs tied to international price referencing were also announced. Trading volume approached 19 million shares.
21 December 2025
··
Medical Properties Trust (MPW) Stock Forecast and News on Dec. 20, 2025: Dividend Hike, Prospect Bankruptcy Developments, and Wall Street Price Targets

Medical Properties Trust (MPW) Stock Forecast and News on Dec. 20, 2025: Dividend Hike, Prospect Bankruptcy Developments, and Wall Street Price Targets

Medical Properties Trust shares closed at $5.13 on Dec. 19, 2025, following a year marked by tenant restructurings and asset sales. The board raised its quarterly dividend to $0.09, payable Jan. 8, 2026. Prospect Medical Holdings, a key tenant, received court approval to exit bankruptcy after a hearing in Texas. Investors remain focused on dividend yield and headline risks tied to tenant stability.
21 December 2025
··
Walmart Stock (WMT) News and Forecasts for Dec. 20, 2025: Analysts Stay Positive, but Valuation Debate Heats Up

Walmart Stock (WMT) News and Forecasts for Dec. 20, 2025: Analysts Stay Positive, but Valuation Debate Heats Up

Walmart closed at $114.36 on Dec. 19, 2025, near its 52-week high of $117.45, with a market cap around $911–$920 billion. Analysts split over its valuation: some warn the 40x earnings multiple is risky, while others say tech-driven growth isn’t fully priced in. Q3 FY26 results showed 5.8% revenue growth and strong gains in eCommerce and advertising.
21 December 2025
·
PepsiCo Stock (NASDAQ: PEP) News & Forecasts (Dec. 20, 2025): Elliott-Backed Cost Cuts, Walmart Lawsuit Overhang, and What Analysts Expect for 2026

PepsiCo Stock (NASDAQ: PEP) News & Forecasts (Dec. 20, 2025): Elliott-Backed Cost Cuts, Walmart Lawsuit Overhang, and What Analysts Expect for 2026

PepsiCo shares closed near $148 on Friday, down about 2.6% for 2025, as the company announced a major 2026 cost-cutting and portfolio reset influenced by Elliott Investment Management. PepsiCo plans to cut nearly 20% of U.S. SKUs and launch new products like Doritos Protein. A new lawsuit accuses PepsiCo and Walmart of price-fixing. Wall Street is adjusting price targets as these developments unfold.
21 December 2025
··
EchoStar (SATS) Stock in Late December 2025: SpaceX Spectrum Deal, Analyst Price Targets, and the FCC/DOJ Risk Investors Can’t Ignore

EchoStar (SATS) Stock in Late December 2025: SpaceX Spectrum Deal, Analyst Price Targets, and the FCC/DOJ Risk Investors Can’t Ignore

EchoStar shares hit a 52-week high near $111.39 on December 19, trading around $106 by session’s end, with market capitalization close to $30 billion. The surge follows a $23 billion spectrum sale to AT&T and a $17 billion deal with SpaceX, drawing increased regulatory scrutiny. The stock delivered triple-digit percentage gains over the prior 12 months. Analysts now anchor forecasts around $103.91.
21 December 2025
Chevron Stock (CVX) in Focus After Dec. 20 Venezuela Headlines: What the Latest News, Forecasts, and Analyst Targets Mean for 2026

Chevron Stock (CVX) in Focus After Dec. 20 Venezuela Headlines: What the Latest News, Forecasts, and Analyst Targets Mean for 2026

The U.S. seized a Panama-flagged oil tanker near Venezuela on Dec. 20, escalating enforcement against Venezuelan oil shipments, Reuters reported. Chevron, the only U.S. major operating there under special authorization, faces increased operational and compliance risks as loaded vessels stall in Venezuelan waters to avoid seizure. Oil prices rose after President Trump declared a “total and complete blockade” of sanctioned tankers earlier in the week.
21 December 2025
··
McDonald’s Stock (NYSE: MCD) Outlook for 2026: Latest News, Dividend Update, and Analyst Price Targets as of Dec. 20, 2025

McDonald’s Stock (NYSE: MCD) Outlook for 2026: Latest News, Dividend Update, and Analyst Price Targets as of Dec. 20, 2025

McDonald’s shares closed at $315.84 Friday, down 1.19%, trading near the top of their 52-week range. The company will implement stricter global franchising standards on Jan. 1, 2026, aiming to reinforce “value leadership.” Franchisees will retain pricing authority, but McDonald’s will monitor pricing and may penalize noncompliance. Market cap stands at about $224.93 billion.
21 December 2025
··
3M Stock (MMM) News, Forecasts and Analyst Outlook for Dec. 20, 2025: Margin Gains Meet PFAS Deadlines

3M Stock (MMM) News, Forecasts and Analyst Outlook for Dec. 20, 2025: Margin Gains Meet PFAS Deadlines

3M shares closed at $161.96 on Dec. 20, 2025, putting the company’s market cap in the mid-$80 billion range, down from early December highs but well above spring levels. The stock sits about 7% below its 52-week peak. 3M raised its annual profit forecast twice in 2025, citing higher-margin products and cost controls. The company also reduced its estimate of 2025 tariff-related impacts as trade tensions eased.
21 December 2025
··
1 … 1,278 1,279 1,280 1,281 1,282 … 2,088

Stock Market Today

  • Goldman Sachs Acquires 2.87% Stake in Qiagen via Shares and Derivatives
    June 21, 2026, 12:13 AM EDT. Qiagen disclosed that Goldman Sachs has accumulated a 2.87% stake through a combination of ordinary shares, call options, warrants, swaps, and convertible bonds. The position is held indirectly across multiple Goldman Sachs entities with both physical and cash settlements. This notable institutional holding could impact Qiagen's shareholder structure and market perception. Qiagen clarified it is not responsible for the accuracy of the Dutch Authority for the Financial Markets notification but highlighted the increased institutional interest. Qiagen, a global life sciences firm, trades on several exchanges including NYSE, boasting a $7.61 billion market cap and an average volume of over 2 million shares. Current analyst consensus rates Qiagen stock as Hold with a $36 price target.

Latest articles

Home Depot shares finish week up as investors weigh housing numbers

Home Depot shares finish week up as investors weigh housing numbers

21 June 2026
Home Depot jumped 2.1% to $334.28 in a shortened week as Wall Street rallied, but weak U.S. housing starts and upcoming May new-home-sales data keep pressure on the home-improvement outlook; the company reaffirmed 2026 sales and earnings targets despite volatile conditions and persistent housing affordability concerns.
Go toTop